SMARCA4 and atypical teratoid rhabdoid tumor: Then a test for identification of a germline heterozygous pathogenic variant in SMARCA4 or SMARCB1 by molecular genetic testing is indicated, at any age, in all cases of ATRT diagnosis (10–12).